Research workbench
Human SIRT5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29
Analyse Human SIRT5 in complex with stalled peptidylimidate intermediate of inhibitory… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6EQS
- Type
- protein
- Length
- 1,086 residues
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- NAD-dependent protein deacylase sirtuin-5, mitochondrial
- EC
- 3.5.1.-
- UniProt
- Q9NXA8
- Ligands
- BV8, ZN
- Pockets
- 11 · best druggability 0.82
Structure
x-ray diffraction · 4 distinct chains · 38% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-) | protein | 269 | 38% helix, 19% strand | Q9NXA8 |
| B | NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-) | protein | 268 | 39% helix, 19% strand | Q9NXA8 |
| C | NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-) | protein | 274 | 38% helix, 19% strand | Q9NXA8 |
| D | NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-) | protein | 275 | 37% helix, 19% strand | Q9NXA8 |
Ligands and binding sites
- BV8 · 3-[[(~{Z})-~{C}-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]sulfanyl-~{N}-[(5~{S})-6-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanylidene-1-(propan-2-ylamino)propan-2-yl]amino]-6-oxidanylidene-5-(phenylmethoxycarbonylamino) hexyl]carbonimidoyl]amino]propanoic acid · ligand · 4 copies · chains A, D, B, C
- ZN · Zinc ion · metal · 4 copies · chains A, B, C, D
- EDO · 1,2-ethanediol · additive · 15 copies · chains A, B, C, D
- BU2 · 1,3-butanediol · additive · 8 copies · chains A, B, C, D
- DMS · Dimethyl sulfoxide · additive · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1021 | 0.82 | 0.83 | 102 | BV8, EDO |
| 2 | 933 | 0.80 | 0.82 | 94 | BV8, EDO, BU2 |
| 3 | 460 | 0.77 | 0.85 | 58 | BV8, EDO, DMS |
| 4 | 443 | 0.77 | 0.85 | 59 | BV8, EDO, BU2 |
| 5 | 833 | 0.72 | 0.77 | 93 | BU2 |
Interfaces
3 interfaces between chains.
- A–D · 527 Ų buried · 4 hydrogen bonds · protein-protein
- B–C · 490 Ų buried · 4 hydrogen bonds · protein-protein
- B–D · 357 Ų buried · 0 hydrogen bonds · protein-protein
Compared structures
- 6EQS · Human Sirt5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29 · the same entry in another collection · chain D against D, TM-score 1.00
- Q9NXA8 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacylase sirtuin-5… · a predicted model of the same protein · chain B against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9NXA8
- Elsewhere: RCSB PDB 6EQS · PDBe 6EQS · UniProt Q9NXA8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.